vs
ASP Isotopes Inc.(ASPI)与NeuroPace Inc(NPCE)财务数据对比。点击上方公司名可切换其他公司
NeuroPace Inc的季度营收约是ASP Isotopes Inc.的1.6倍($26.6M vs $16.7M),ASP Isotopes Inc.同比增速更快(1295.7% vs 23.9%),NeuroPace Inc自由现金流更多($409.0K vs $-47.4M)
ASP Isotopes Inc.是一家特种材料企业,专注于高纯度定制同位素的研发与生产,产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域,客户覆盖北美、欧洲及亚太地区。
NeuroPace Inc是一家专注于神经调控技术的医疗科技企业,核心产品为可植入式响应神经刺激系统,主要用于治疗药物难治性癫痫,通过与医疗机构合作,为北美及部分全球市场的患者提供个性化治疗方案,降低癫痫发作频率。
ASPI vs NPCE — 直观对比
营收规模更大
NPCE
是对方的1.6倍
$16.7M
营收增速更快
ASPI
高出1271.8%
23.9%
自由现金流更多
NPCE
多$47.8M
$-47.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.7M | $26.6M |
| 净利润 | — | $-2.7M |
| 毛利率 | 12.5% | 77.4% |
| 营业利润率 | — | -6.6% |
| 净利率 | — | -10.3% |
| 营收同比 | 1295.7% | 23.9% |
| 净利润同比 | -586.8% | 48.0% |
| 每股收益(稀释后) | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASPI
NPCE
| Q4 25 | $16.7M | $26.6M | ||
| Q3 25 | $4.9M | $27.4M | ||
| Q2 25 | — | $23.5M | ||
| Q1 25 | — | $22.5M | ||
| Q4 24 | — | $21.5M | ||
| Q3 24 | — | $21.1M | ||
| Q2 24 | — | $19.3M | ||
| Q1 24 | — | $18.1M |
净利润
ASPI
NPCE
| Q4 25 | — | $-2.7M | ||
| Q3 25 | $-12.9M | $-3.5M | ||
| Q2 25 | — | $-8.7M | ||
| Q1 25 | — | $-6.6M | ||
| Q4 24 | — | $-5.3M | ||
| Q3 24 | — | $-5.5M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | — | $-8.9M |
毛利率
ASPI
NPCE
| Q4 25 | 12.5% | 77.4% | ||
| Q3 25 | 8.7% | 77.4% | ||
| Q2 25 | — | 77.1% | ||
| Q1 25 | — | 77.0% | ||
| Q4 24 | — | 75.4% | ||
| Q3 24 | — | 73.2% | ||
| Q2 24 | — | 73.4% | ||
| Q1 24 | — | 73.6% |
营业利润率
ASPI
NPCE
| Q4 25 | — | -6.6% | ||
| Q3 25 | -306.1% | -9.5% | ||
| Q2 25 | — | -29.0% | ||
| Q1 25 | — | -22.9% | ||
| Q4 24 | — | -17.0% | ||
| Q3 24 | — | -20.1% | ||
| Q2 24 | — | -32.4% | ||
| Q1 24 | — | -41.6% |
净利率
ASPI
NPCE
| Q4 25 | — | -10.3% | ||
| Q3 25 | -263.7% | -12.8% | ||
| Q2 25 | — | -36.8% | ||
| Q1 25 | — | -29.3% | ||
| Q4 24 | — | -24.5% | ||
| Q3 24 | — | -25.9% | ||
| Q2 24 | — | -39.0% | ||
| Q1 24 | — | -49.2% |
每股收益(稀释后)
ASPI
NPCE
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.15 | $-0.11 | ||
| Q2 25 | — | $-0.26 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.16 | ||
| Q3 24 | — | $-0.19 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $61.1M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $19.0M |
| 总资产 | $498.0M | $105.6M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势,按日历期对齐
现金及短期投资
ASPI
NPCE
| Q4 25 | $333.3M | $61.1M | ||
| Q3 25 | $113.9M | $60.0M | ||
| Q2 25 | — | $62.1M | ||
| Q1 25 | — | $66.3M | ||
| Q4 24 | — | $52.8M | ||
| Q3 24 | — | $56.8M | ||
| Q2 24 | — | $55.5M | ||
| Q1 24 | — | $58.9M |
总债务
ASPI
NPCE
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
ASPI
NPCE
| Q4 25 | $204.2M | $19.0M | ||
| Q3 25 | $74.1M | $18.5M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $24.3M | ||
| Q4 24 | — | $8.0M | ||
| Q3 24 | — | $9.8M | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | — | $14.3M |
总资产
ASPI
NPCE
| Q4 25 | $498.0M | $105.6M | ||
| Q3 25 | $225.9M | $107.3M | ||
| Q2 25 | — | $106.1M | ||
| Q1 25 | — | $110.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | — | $96.3M | ||
| Q2 24 | — | $94.4M | ||
| Q1 24 | — | $98.9M |
负债/权益比
ASPI
NPCE
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $506.0K |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $409.0K |
| 自由现金流率自由现金流/营收 | -284.7% | 1.5% |
| 资本支出强度资本支出/营收 | 57.9% | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-11.3M |
8季度趋势,按日历期对齐
经营现金流
ASPI
NPCE
| Q4 25 | $-37.8M | $506.0K | ||
| Q3 25 | $-8.9M | $-1.9M | ||
| Q2 25 | — | $-2.1M | ||
| Q1 25 | — | $-7.5M | ||
| Q4 24 | — | $-4.8M | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $-7.5M |
自由现金流
ASPI
NPCE
| Q4 25 | $-47.4M | $409.0K | ||
| Q3 25 | $-12.0M | $-2.0M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | — | $-7.5M | ||
| Q4 24 | — | $-4.8M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | — | $-7.6M |
自由现金流率
ASPI
NPCE
| Q4 25 | -284.7% | 1.5% | ||
| Q3 25 | -245.5% | -7.2% | ||
| Q2 25 | — | -9.6% | ||
| Q1 25 | — | -33.4% | ||
| Q4 24 | — | -22.5% | ||
| Q3 24 | — | -8.7% | ||
| Q2 24 | — | -20.6% | ||
| Q1 24 | — | -42.1% |
资本支出强度
ASPI
NPCE
| Q4 25 | 57.9% | 0.4% | ||
| Q3 25 | 64.4% | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图